Diabetes - type 1

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Risk Factors
• Symptoms
• Life-Threatening Complicati...
• Diagnosis
• Dietary Goals and Exercise...
• Treatment
• Monitoring Tests
• Long-Term Complications
• Transplantation Procedures...
• Prevention
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights New Continuous Glucose Meter System In 2007, the FDA approved the STS-7 System, which monitors glucose levels every 5 minutes during a 7-day period. The STS-7 System, like other continuous glucose meter systems, is designed to be used in combination with traditional fingerstick tests and meters. It does not replace them. - 3 Comments

Psoriasis

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Types of Psoriasis
• Causes
• Risk Factors
• Diagnosis
• Treatment
• Topical Medications
• Systemic Medications
• Phototherapy
• Managing Psoriasis
• Outlook
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Treatment Psoriasis that develops on the hands or feet is often very difficult to treat. However, an advanced clinical trial showed that a medication called efalizumab (Raptiva) effectively cleared or nearly cleared moderate-to-severe symptoms in adults after 12 weeks. Several studies have shown that most people with severe psoriasis who are treated with infliximab (Remicade) have significant improvement in symptoms by week 10. - 0 Comments

Ulcerative colitis

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Symptoms
• Complications
• Risk Factors
• Diagnosis
• Dietary Factors
• Symptom Management
• Medications
• Surgery
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Drug Approval In 2007, the FDA approved LIALDA, the first once-daily mesalamine pill for treating mild-to-moderate ulcerative colitis. Other types of mesalamine need to be taken several times a day. Genetic Research Scientists have made an important discovery by identifying a gene associated with inflammatory bowel disease. - 0 Comments

Crohn's disease

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Symptoms
• Complications
• Risk Factors
• Diagnosis
• Dietary Factors
• Symptom Management
• Medications
• Surgery
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Biologic Drugs

• In February 2007, the FDA approved adalimumab (Humira) for treatment of adult patients with moderate-to-severe Crohn’s disease. Adalimumab and infliximab (Remicade) are now the two biologic drugs approved for Crohn’s disease. Infliximab is approved for treating both adults and children.
• As of August 2007, the FDA was considering approving natalizumab (Tysabri) for moderate-to-severe Crohn’s disease in patients who have not responded to, or cannot tolerate, other therapies. - 0 Comments
  Read More ›

Osteoarthritis

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Symptoms
• Conditions with Similar Sym...
• Risk Factors
• Diagnosis
• Prognosis
• Lifestyle Changes
• Medications
• Alternative and Complementa...
• Surgery
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Pain Medications

• Nonsteroidal anti-inflammatory drugs (NSAIDs) and COX-2 inhibitors work equally well for pain management, but both types of drugs increase the risk for heart attacks, according to an important report from the U.S. Agency for Healthcare Quality and Research.
• The prescription NSAID diclofenac (Voltaren, Cataflam) may present a higher risk for heart attack than other NSAIDs, suggests a 2006 Journal of the American Medical Association study.
• Standard osteoarthritis medications provide moderate pain relief for only 2 - 3 weeks, suggests a 2007 review in the European Journal of Pain.

Acupuncture Acupuncture may be helpful for people with knee and hip osteoarthritis, according to several 2006 studies:

• An Annals of Internal Medicine study of 1,007 people with chronic osteoarthritis knee pain indicated that patients who received acupuncture plus standard care had greater improvement than those who received only physical therapy and anti-inflammatory drugs.
• An Arthritis and Rheumatism study of 3,663 patients with chronic osteoarthritis knee or hip pain suggested that acupuncture plus routine care can provide significant improvements in pain relief and quality of life. In both studies, the benefits of acupuncture were sustained for up to 6 months after treatment completion.

Exercise and Knee Osteoarthritis Weight-bearing exercise (walking, jogging) neither prevents nor increases the risk of knee osteoarthritis in healthy middle-aged and elderly people, suggests a 2007 study in Arthritis and Rheumatism. - 0 Comments

Urinary incontinence

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Stress Incontinence
• Urge Incontinence
• Overflow Incontinence
• Functional Incontinence
• Risk Factors
• Diagnosis
• Prognosis
• Treatment
• Lifestyle Changes
• Other Treatments
• Behavioral Treatments
• Medications
• Surgery
• Other Procedures
• Catheters and Collection De...
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Sling Procedure Versus Burch Colposuspension The sling procedure is better than Burch colposuspension in treating stress incontinence but may cause more post-operative urinary complications, according to results from an important 2007 New England Journal of Medicine study. In the first large-scale clinical trial to directly compare these two types of surgery, 47% of women who underwent the sling procedure had no urinary incontinence 2 years after surgery, compared with 38% of women who received the Burch procedure. However, 63% of women who had the sling procedure (and 47% of women who underwent the Burch procedure) experienced urinary tract infections following surgery. - 0 Comments